Siegfried Holding AG SFZN

Morningstar Rating
CHF 69.80 −0.80 (1.13%)
View Full Chart

Company Report

Price vs Fair Value

SFZN is trading at a LOCK|VcF$Y? premium.
Price
CHF 69.80
Fair Value
r&#
Uncertainty
LOCK|#RH<
1-Star Price
LOCK|#.^
5-Star Price
LOCK|.b#
Economic Moat
LOCK|Xj^&s
Capital Allocation
LOCK|&F&Js?

Bulls Say, Bears Say

Bulls

As drug manufacturing becomes more complex, the long-term outlook appears bright as biotechnology and pharmaceutical firms will be more reliant on outsourced manufacturing.

Bears

Siegfried is vulnerable to facility closures, whether from natural disasters or manufacturing issues. A warning letter from the FDA or another regulatory agency can result in manufacturing delays or closures.

Trading Information

Previous Close Price
CHF 70.60
Day Range
CHF 69.65–71.20
52-Week Range
CHF 65.05–101.60
Bid/Ask
CHF 69.85 / CHF 72.00
Shares Outstanding
43.81M
Market Cap
CHF 3.06B
Volume/Avg
85,824 / 102,847

Key Statistics

Price/Earnings (Normalized)
18.14
Price/Sales
2.30
Dividend Yield (Trailing)
0.57%
Dividend Yield (Forward)
0.57%
Dividend Payment Schedule
Apr
Total Yield
0.81%

Company Profile

Siegfried is a global contract development and manufacturing organization. It derives its revenue primarily from long-term supply agreements with biotechnology and pharmaceutical customers. Siegfried develops and manufactures active pharmaceutical ingredients, finished dosage forms (tablets, capsules, sterile vials, ampules, cartridges, and ointments), and viral vectors. The company provides these services throughout the entire drug lifecycle, including chemical and analytical development, pilot manufacturing, and commercial-scale manufacturing. Siegfried has a large global footprint with 16 production sites on four continents.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Mid Core
Total Number of Employees
4,454

Competitors

Valuation

Metric
SFZN
LONN
02269
Price/Earnings (Normalized)
18.1434.2835.59
Price/Book Value
3.114.824.35
Price/Sales
2.306.218.87
Price/Cash Flow
13.0220.0324.07
Price/Earnings
SFZN
LONN
02269

Financial Strength

Metric
SFZN
LONN
02269
Quick Ratio
1.360.592.64
Current Ratio
3.451.663.32
Interest Coverage
24.559.2967.52
Quick Ratio
SFZN
LONN
02269

Profitability

Metric
SFZN
LONN
02269
Return on Assets (Normalized)
7.56%6.27%10.38%
Return on Equity (Normalized)
15.73%13.97%14.65%
Return on Invested Capital (Normalized)
10.10%9.75%11.25%
Return on Assets
SFZN
LONN
02269

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Merck KGaA ADR
MKKGY
LOCK|qv!gP!gLOCK|q%d@?$66B
Teva Pharmaceutical Industries Ltd
TEVA
LOCK|ss?^?l?LOCK|!<TVj$46B
Haleon PLC ADR
HLN
LOCK|&X#Z>Q!LOCK|&Bh$38B
Zoetis Inc Class A
ZTS
LOCK|@$Ng>z<LOCK|LJ$29B
Viatris Inc
VTRS
LOCK|P&><@#BLOCK|?F$20B
Elanco Animal Health Inc
ELAN
LOCK|^rLOCK|!<$11B
Dr Reddy's Laboratories Ltd ADR
RDY
LOCK|Mj<jtNjLOCK|>X<$10B
Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
LOCK|%Q?<DrLOCK|#D$7B
Prestige Consumer Healthcare Inc
PBH
LOCK|pY?m?S?LOCK|>VTZ$2B
Perrigo Co PLC
PRGO
LOCK|CjMBdsLOCK|%cC$2B

Sponsor Center